Corporate partnership

QuantiBact aims at establishing partnerships with major biotech and diagnostic companies for subsequent commercialization of diagnostic assays through joint development of new technologies and new products and processes.
If you are interested in cooperation and partnership-embedded licensing possibilities with QuantiBact, Please contact:

CEO: Palle Schelde, M.Sc.

CSO: Gorm Lisby, M.D., Ph.D.

^  Top
Previous page: Update history  Next page: Investors